BioLineRx (BLRX) Other Non-Current Assets (2012 - 2019)
BioLineRx (BLRX) recorded quarterly Other Non-Current Assets of $56000.0 in Q4 2019, down 5.08% quarter-over-quarter from $59000.0 in Q3 2019, and up 1020.0% on a YoY basis from $5000.0 in Q4 2018.
BioLineRx (BLRX) Other Non-Current Assets (2012 - 2019) Analysis & Trends
BioLineRx's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $56000.0 for Q4 2019.
- In Q4 2019, Other Non-Current Assets rose 1020.0% year-over-year to $56000.0; the TTM figure through Dec 2019 stood at $56000.0 (up 1020.0% YoY), while the FY2019 annual figure was $56000.0, up 1020.0% from the prior year.
- Other Non-Current Assets was $56000.0 for Q4 2019 at BioLineRx, down from $59000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q4 2016 to a low of -$9000.0 in Q4 2015.
- Historically, Other Non-Current Assets has averaged $77850.0 across 5 years, with a median of $52000.0 in 2015.
- The sharpest annual moves came in 2016 and 2017: Other Non-Current Assets surged 11211.11% in 2016, then sank 300.0% in 2017.
- A 5-year view of Other Non-Current Assets shows it stood at -$9000.0 in 2015, then soared by 11211.11% to $1.0 million in 2016, then slumped by 100.9% to -$9000.0 in 2017, then surged by 155.56% to $5000.0 in 2018, then jumped by 1020.0% to $56000.0 in 2019.
- The last three Other Non-Current Assets figures came in at $56000.0 (Q4 2019), $59000.0 (Q3 2019), and -$4000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 56,000.00 |
| Sep 30, 2019 | 59,000.00 |
| Jun 30, 2019 | -4,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 5,000.00 |
| Sep 30, 2018 | 66,000.00 |
| Jun 30, 2018 | 63,000.00 |
| Mar 31, 2018 | 60,000.00 |
| Dec 31, 2017 | -9,000.00 |
| Sep 30, 2017 | -8,000.00 |
| Jun 30, 2017 | -1,000.00 |
| Mar 31, 2017 | 55,000.00 |
| Dec 31, 2016 | 1.00 Mn |
| Sep 30, 2016 | 4,000.00 |
| Jun 30, 2016 | 54,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Dec 31, 2015 | -9,000.00 |
| Sep 30, 2015 | 56,000.00 |
| Jun 30, 2015 | 57,000.00 |
| Mar 31, 2015 | 50,000.00 |